Bio-engineered Stent Market By Material Type (Medical-grade Stainless Steel, Cobalt-Chromium Alloy, Others), By Disease Indication (Coronary Heart Disease, Ischemic Heart Disease, Peripheral Artery Disease, Other), By End-User Segment (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Growth, Future Prospects, and Competitive Analysis, 2019 - 2027
"Bio-engineered stent market to exhibit dynamic growth during the forecast period"
The global bio-engineered stent market is growing proficiently, expected to grow at a CAGR of 7.1%. Globally, growing prevalence of coronary heart diseases and other hearing related disorders will drive the market growth. Growing awareness about new medical technology along with the launch of advanced bio-engineered cardiac stents or coronary stents with integrated biological solutions and enhanced biomaterials are factors driving the overall growth of bio-engineered stent market on a global scale.
"Medical grade stainless steel segment expected to register higher growth by the end of 2027"
Advancement in biodegradable metals for cardiovascular stents along with the development in the field of alloys will enhance the overall growth of the market. Metallic stents are usually used to endorse revascularization and preserve the patency of damaged arteries following angioplasty procedures. The intrinsic surface and mechanical properties of metals make them more attractive. For e.g. Genous Bio-engineered stent, it has an exceptional dual helix design that delivers natural conformability and has endothelial progenitor cell capture technology to defend counter to thrombus (blood clotting) and minimizes the recurrence of abnormal narrowing of an artery or valve by accelerating the natural restorative process.
"Coronary heart diseases to witness a significant CAGR"
Increasing hospital admissions for coronary heart-related disorders and its treatment generated maximum revenue share in 2018. Additionally, large patient pool with cardiovascular diseases and individuals for the early diagnosis of heart related conditions on a global scale will drive the market growth globally. In 2017, according to statistics by American College of Cardiology, cardiovascular disease accounted for more than 800,000 deaths in the United States. Additionally, increasing prevalence for acute coronary syndrome, ischemic heart disease, and peripheral artery disease will drive the demand for bio-engineered stent market. Advancement in bioengineering technology, FDA approval of new products, increasing geriatric population, and awareness, offers potential advantage as an elective treatment to high cost cardiac surgical procedures, and wide usage of top applications in the stent industry.
"Increasing geriatric population, FDA approval and the presence of top manufacturers holds North America in dominant position"
In 2018, the U.S. produced maximum revenue in the bio-engineered stent market due to an increase in prevalence for cardiovascular disorders, increasing hospitals admissions for coronary heart disease treatment and launch of new products will boost the market growth. Presently, more than 92 million U.S. citizens are living with some form of cardiovascular condition or the after-effects of stroke. According to a 2016 study by American Heart Association, overall direct medical expenditure of cardiovascular diseases are projected to surge to around $749 billion in 2035 globally. Existence of numerous treatment options further upsurges patient compliance in safety and efficiency of treatment for cardiovascular-related disorders which in turn expected to drive the market growth. However, the higher expense of surgical procedures, less popularity among the physicians in the developed regions, complexity in R&D, and controlled returns may hamper the overall market growth on a global scale.
"Increased research and development with strong product pipelines in the developed regions"
Major players in the bio-engineered stent market are ORBUSNEICH MEDICAL, Medtronic, plc., Abbott Laboratories, Vascular Concepts, C. R. Bard, Lombard Medical Technologies, Biotronik SE & Co. KG, Terumo Corporation, Endologix, Inc., Translumina GmbH and others. Major companies are emerging with advanced technologies with integrated biological solutions. Acquisitions, partnership agreements and enhanced R&D on medical technology will invent the development of bio-engineered stent market in the emerging nations in the near future.
Historical & Forecast Period
This study report represents analysis for each segment from 2017 to 2027 considering 2018 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027.
Report Scope by Segments
Market Segmentation
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2017-2027 |
| Base Year | 2018 |
| Forecast Period | 2019-2027 |
| Historical Year | 2017 |
| Unit | USD Million |
| Segmentation |
Material Type (2017–2027; US$ Mn) |
|
Disease Indication (2017–2027; US$ Mn) |
|
|
End-User Segment (2017–2027; US$ Mn) |
|
|
Geography Segment (2017–2027; US$ Mn) |
The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that give a better market understanding of the overall bio-engineered stent market. Additionally, the global report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.
Key questions answered in this report
- What are the current market trends and dynamics in the bio-engineered stent market and valuable opportunities for emerging players?
- Which segment accounts for the fastest CAGR during the forecast period?
- Which material type segment holds a larger market share and why?
- Are low and middle-income economies investing in the bio-engineered stent market?
- What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation
2. Executive Summary
2.1. Market Snapshot: Global Bio-engineered Stent Market
2.2. Global Bio-engineered Stent Market, by Material Type, 2018 (US$ Bn)
2.3. Global Bio-engineered Stent Market, by Disease Indication, 2018 (US$ Bn)
2.4. Global Bio-engineered Stent Market, by End-user, 2018 (US$ Bn)
2.5. Global Bio-engineered Stent Market, by Geography, 2018 (US$ Bn)
3. Market Dynamics
3.1. Introduction
3.1.1. Global Bio-engineered Stent Market Value, 2017-2027, (US$ Bn)
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.3. Attractive Investment Proposition, by Geography, 2018
3.4. Market Positioning of Key Players, 2018
3.4.1. Major Strategies Adopted by Key Players
4. Global Bio-engineered Stent Market, by Material Type , 2017-2027 (US$ Bn)
4.1. Overview
4.2. Medical-grade Stainless Steel
4.3. Cobalt Chromium Alloy
4.4. Others (Tantalum, Gold, Nitinol, Polymers)
5. Global Bio-engineered Stent Market, by Disease Indication, 2017-2027 (US$ Bn)
5.1. Overview
5.2. Coronary Heart Disease
5.3. Ischemic Heart Disease
5.4. Peripheral Artery Disease
5.5. Other Cardiovascular Diseases
6. Global Bio-engineered Stent Market, by End-user, 2017-2027 (US$ Bn)
6.1. Hospitals
6.2. Specialty Clinics
6.3. Ambulatory Surgical Centers
7. North America Bio-engineered Stent Market Analysis, 2017-2027 (US$ Bn)
7.1. Overview
7.1.1. North America Bio-engineered Stent Market Value and Growth, 2017-2027, (US$ Bn)
7.2. North America Bio-engineered Stent Market Value, By Material Type, 2017-2027 (US$ Bn)
7.2.1. Market Analysis
7.3. North America Bio-engineered Stent Market Value, By Disease Indication, 2017-2027 (US$ Bn)
7.3.1. Market Analysis
7.4. North America Bio-engineered Stent Market Value, By End-user, 2017-2027 (US$ Bn)
7.4.1. Market Analysis
7.5. North America Bio-engineered Stent Market Value, By Region/Country, 2017-2027 (US$ Bn)
7.5.1. Market Analysis
7.5.2. U.S.
7.5.3. Rest of North America
8. Europe Bio-engineered Stent Market Analysis, 2017-2027 (US$ Bn)
8.1. Overview
8.1.1. Europe Bio-engineered Stent Market Value and Growth, 2017-2027, (US$ Bn)
8.2. Europe Bio-engineered Stent Market Value, By Material Type, 2017-2027 (US$ Bn)
8.2.1. Market Analysis
8.3. Europe Bio-engineered Stent Market Value, By Disease Indication, 2017-2027 (US$ Bn)
8.3.1. Market Analysis
8.4. Europe Bio-engineered Stent Market Value, By Component, 2017-2027 (US$ Bn)
8.4.1. Market Analysis
8.5. Europe Bio-engineered Stent Market Value, By Connectivity Type, 2017-2027 (US$ Bn)
8.5.1. Market Analysis
8.6. Europe Bio-engineered Stent Market Value, By End-user, 2017-2027 (US$ Bn)
8.6.1. Market Analysis
8.7. Europe Bio-engineered Stent Market Value, By Region/Country, 2017-2027 (US$ Bn)
8.7.1. Market Analysis
8.7.2. U.K.
8.7.3. Germany
8.7.4. France
8.7.5. Rest of Europe
9. Asia Pacific Bio-engineered Stent Market Analysis, 2017-2027 (US$ Bn)
9.1. Overview
9.1.1. Asia Pacific Bio-engineered Stent Market Value and Growth, 2017-2027, (US$ Bn)
9.2. Asia Pacific Bio-engineered Stent Market Value, By Material Type, 2017-2027 (US$ Bn)
9.2.1. Market Analysis
9.3. Asia Pacific Bio-engineered Stent Market Value, By Disease Indication, 2017-2027 (US$ Bn)
9.3.1. Market Analysis
9.4. Asia Pacific Bio-engineered Stent Market Value, By Component, 2017-2027 (US$ Bn)
9.4.1. Market Analysis
9.5. Asia Pacific Bio-engineered Stent Market Value, By Connectivity Type, 2017-2027 (US$ Bn)
9.5.1. Market Analysis
9.6. Asia Pacific Bio-engineered Stent Market Value, By End-user, 2017-2027 (US$ Bn)
9.6.1. Market Analysis
9.7. Asia Pacific Bio-engineered Stent Market Value, By Region/Country, 2017-2027 (US$ Bn)
9.7.1. Market Analysis
9.7.2. Japan
9.7.3. China
9.7.4. India
9.7.5. Rest of Asia Pacific
10. Rest of the World Bio-engineered Stent Market Analysis, 2017-2027 (US$ Bn)
10.1. Overview
10.1.1. Rest of the World Bio-engineered Stent Market Value and Growth, 2017-2027, (US$ Bn)
10.2. Rest of the World Bio-engineered Stent Market Value, By Material Type, 2017-2027 (US$ Bn)
10.2.1. Market Analysis
10.3. Rest of the World Bio-engineered Stent Market Value, By Disease Indication, 2017-2027 (US$ Bn)
10.3.1. Market Analysis
10.4. Rest of the World Bio-engineered Stent Market Value, By Component, 2017-2027 (US$ Bn)
10.4.1. Market Analysis
10.5. Rest of the World Bio-engineered Stent Market Value, By Connectivity Type, 2017-2027 (US$ Bn)
10.5.1. Market Analysis
10.6. Rest of the World Bio-engineered Stent Market Value, By End-user, 2017-2027 (US$ Bn)
10.6.1. Market Analysis
10.7. Rest of the World Bio-engineered Stent Market Value, By Region, 2017-2027 (US$ Bn)
10.7.1. Market Analysis
10.7.2. Middle East & Africa
10.7.3. Latin America
11. Company Profiles
11.1. ORBUSNEICH MEDICAL
11.2. Medtronic, plc.
11.3. Abbott Laboratories
11.4. Vascular Concepts
11.5. C. R. Bard
11.6. Lombard Medical Technologies
11.7. Biotronik SE & Co. KG
11.8. Terumo Corporation
11.9. Endologix, Inc.
11.10. Translumina GmbH
TABLE 1 Market Snapshot: Global Bio-engineered Stent Market Value
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Restraints
TABLE 4 Global Bio-engineered Stent Market, by Material Type, 2017-2027 (US$ Bn)
TABLE 5 Global Bio-engineered Stent Market, by Disease Indication, 2017-2027 (US$ Bn)
TABLE 6 Global Bio-engineered Stent Market, by End-user, 2017 - 2027 (US$ Bn)
TABLE 7 Global Bio-engineered Stent Market, by Geography, 2017-2027 (US$ Bn)
TABLE 8 North America Bio-engineered Stent Market, by Material Type, 2017-2027 (US$ Bn)
TABLE 9 North America Bio-engineered Stent Market, by Disease Indication, 2017-2027 (US$ Bn)
TABLE 10 North America Bio-engineered Stent Market, by End-user, 2017 - 2027 (US$ Bn)
TABLE 11 North America Bio-engineered Stent Market Value, by Region/Country, 2017-2027 (US$ Bn)
TABLE 12 Europe Bio-engineered Stent Market, by Material Type, 2017-2027 (US$ Bn)
TABLE 13 Europe Bio-engineered Stent Market, by Disease Indication, 2017-2027 (US$ Bn)
TABLE 14 Europe Bio-engineered Stent Market, by End-user, 2017 - 2027 (US$ Bn)
TABLE 15 Europe Bio-engineered Stent Market Value, by Region/Country, 2017-2027 (US$ Bn)
TABLE 16 Asia Pacific Bio-engineered Stent Market, by Material Type, 2017-2027 (US$ Bn)
TABLE 17 Asia Pacific Bio-engineered Stent Market, by Disease Indication, 2017 -2027 (US$ Bn)
TABLE 18 Asia Pacific Bio-engineered Stent Market, by End-user, 2017 - 2027 (US$ Bn)
TABLE 19 Asia Pacific Bio-engineered Stent Market Value, by Region/Country, 2017-2027 (US$ Bn)
TABLE 20 Rest of the World Bio-engineered Stent Market, by Material Type, 2017-2027 (US$ Bn)
TABLE 21 Rest of the World Bio-engineered Stent Market, by Disease Indication, 2017-2027 (US$ Bn)
TABLE 22 Rest of the World Bio-engineered Stent Market, by End-user, 2017 - 2027 (US$ Bn)
TABLE 23 Rest of the World Bio-engineered Stent Market Value, by Region, 2017-2027 (US$ Bn)
TABLE 24 ORBUSNEICH MEDICAL: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Overview and Recent Development)
TABLE 25 Medtronic, plc.: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Overview and Recent Development)
TABLE 26 Abbott Laboratories: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Overview and Recent Development)
TABLE 27 Vascular Concepts: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Overview and Recent Development)
TABLE 28 C. R. Bard.: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Overview and Recent Development)
TABLE 29 Lombard Medical Technologies: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Overview and Recent Development)
TABLE 30 Biotronik SE & Co. KG: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Overview and Recent Development)
TABLE 31 Terumo Corporation: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Overview and Recent Development)
TABLE 32 Endologix, Inc.: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Overview and Recent Development)
TABLE 33 Translumina GmbH: Company Snapshot (Business Description; Product Portfolio; Financial Information; Business Overview and Recent Development)
FIG. 1 Global Bio-engineered Stent Market: Research Methodology
FIG. 2 Market Size Estimation – Top-Down and Bottom Up Approach
FIG. 3 Global Bio-engineered Stent Market Segmentation
FIG. 4 Global Bio-engineered Stent Market, by Material Type, 2018 (US$ Bn)
FIG. 5 Global Bio-engineered Stent Market, by Disease Indication, 2018 (US$ Bn)
FIG. 6 Global Bio-engineered Stent Market, by End-user, 2018 (US$ Bn)
FIG. 7 Global Bio-engineered Stent Market, by Geography, 2018 (US$ Bn)
FIG. 8 Global Bio-engineered Stent Market Value, 2017-2027, (US$ Bn) and (Y-o-Y%)
FIG. 9 Attractive Investment Proposition, by Geography, 2018
FIG. 10 Global Market Positioning of Key Bio-engineered Stent Providers, 2018
FIG. 11 Global Bio-engineered Stent Market Value Share, by Material Type, 2018 & 2027 (Value %)
FIG. 12 Global Medical-grade Stainless Steel Market Value, 2017-2027, (US$ Bn)
FIG. 13 Global Cobalt Chromium Alloy Market Value, 2017-2027, (US$ Bn)
FIG. 13 Global Others Material Type Market Value, 2017-2027, (US$ Bn)
FIG. 14 Global Bio-engineered Stent Market Value Share, by Disease Indication, 2018 & 2027 (Value %)
FIG. 15 Global Coronary Heart Disease Market Value, 2017-2027, (US$ Bn)
FIG. 16 Global Ischemic Heart Disease Market Value, 2017-2027, (US$ Bn)
FIG. 17 Global Peripheral Artery Disease Market Value, 2017-2027, (US$ Bn)
FIG. 18 Global Bio-engineered Stent Market Value for Other Cardiovascular Diseases, 2017-2027, (US$ Bn)
FIG. 19 Global Bio-engineered Stent Market Value Share, by End-user, 2018 & 2027 (Value %)
FIG. 20 Global Bio-engineered Stent Market Value for Hospitals, 2017-2027, (US$ Bn)
FIG. 21 Global Bio-engineered Stent Market Value for Clinics, 2017-2027, (US$ Bn)
FIG. 22 Global Bio-engineered Stent Market Value for Ambulatory Surgical Centers, 2017-2027, (US$ Bn)
FIG. 23 North America Bio-engineered Stent Market Value, 2017-2027, (US$ Bn)
FIG. 24 Europe Bio-engineered Stent Market Value, 2017-2027, (US$ Bn)
FIG. 25 Asia Pacific Bio-engineered Stent Market Value, 2017-2027, (US$ Bn)
FIG. 26 RoW Bio-engineered Stent Market Value, 2017-2027, (US$ Bn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)